Paul Edison
Paul Edison
Professor of Neuroscience, Imperial College London. MD, PhD, MPhil, MRCP, FRCP
Verified email at - Homepage
Cited by
Cited by
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
F Leng, P Edison
Nature Reviews Neurology 17 (3), 157-172, 2021
Long covid—mechanisms, risk factors, and management
H Crook, S Raza, J Nowell, M Young, P Edison
bmj 374, 2021
Neuroinflammation in Alzheimer's disease: current evidence and future directions
V Calsolaro, P Edison
Alzheimer's & dementia 12 (6), 719-732, 2016
Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R) PK11195-PET and [11C] PIB-PET study
P Edison, HA Archer, A Gerhard, R Hinz, N Pavese, FE Turkheimer, ...
Neurobiology of disease 32 (3), 412-419, 2008
Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C] PIB and [18F] FDG PET study
P Edison, HA Archer, R Hinz, A Hammers, N Pavese, YF Tai, G Hotton, ...
Neurology 68 (7), 501-508, 2007
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
A Okello, J Koivunen, P Edison, HA Archer, FE Turkheimer, K Nagren, ...
Neurology 73 (10), 754-760, 2009
Amyloid load in Parkinson’s disease dementia and Lewy body dementia measured with [11C] PIB positron emission tomography
P Edison, CC Rowe, JO Rinne, S Ng, I Ahmed, N Kemppainen, ...
Journal of Neurology, Neurosurgery & Psychiatry 79 (12), 1331-1338, 2008
Microglial activation and amyloid deposition in mild cognitive impairment: a PET study
A Okello, P Edison, HA Archer, FE Turkheimer, J Kennedy, R Bullock, ...
Neurology 72 (1), 56-62, 2009
An early and late peak in microglial activation in Alzheimer’s disease trajectory
Z Fan, DJ Brooks, A Okello, P Edison
Brain 140 (3), 792-803, 2017
Reference and target region modeling of [11C]-(R)-PK11195 brain studies
FE Turkheimer, P Edison, N Pavese, F Roncaroli, AN Anderson, ...
Journal of Nuclear Medicine 48 (1), 158-167, 2007
Drug repositioning for Alzheimer's disease
A Corbett, J Pickett, A Burns, J Corcoran, SB Dunnett, P Edison, JJ Hagan, ...
Nature Reviews Drug Discovery 11 (11), 833-846, 2012
Improving recruitment of older people to research through good practice
MET McMurdo, H Roberts, S Parker, N Wyatt, H May, C Goodman, ...
Age and ageing 40 (6), 659-665, 2011
Microglial activation and tau propagate jointly across Braak stages
TA Pascoal, AL Benedet, NJ Ashton, MS Kang, J Therriault, M Chamoun, ...
Nature medicine 27 (9), 1592-1599, 2021
Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia
P Edison, I Ahmed, Z Fan, R Hinz, G Gelosa, K Ray Chaudhuri, Z Walker, ...
Neuropsychopharmacology 38 (6), 938-949, 2013
Amyloid load and cerebral atrophy in Alzheimer's disease: An 11C‐PIB positron emission tomography study
HA Archer, P Edison, DJ Brooks, J Barnes, C Frost, T Yeatman, NC Fox, ...
Annals of neurology 60 (1), 145-147, 2006
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease
M Dani, M Wood, R Mizoguchi, Z Fan, Z Walker, R Morgan, R Hinz, M Biju, ...
Brain 141 (9), 2740-2754, 2018
A European multicentre PET study of fibrillar amyloid in Alzheimer’s disease
A Nordberg, SF Carter, J Rinne, A Drzezga, DJ Brooks, R Vandenberghe, ...
European journal of nuclear medicine and molecular imaging 40, 104-114, 2013
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia
Z Fan, Y Aman, I Ahmed, G Chetelat, B Landeau, KR Chaudhuri, ...
Alzheimer's & Dementia 11 (6), 608-621. e7, 2015
Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer’s disease
P Parbo, R Ismail, KV Hansen, A Amidi, FH Mårup, H Gottrup, ...
Brain 140 (7), 2002-2011, 2017
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
GD Femminella, E Frangou, SB Love, G Busza, C Holmes, C Ritchie, ...
Trials 20, 1-10, 2019
The system can't perform the operation now. Try again later.
Articles 1–20